Horiba Ltd (HRIBF)
61.78
0.00 (0.00%)
USD |
OTCM |
Dec 16, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 2.592B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | -7.92% |
| Valuation | |
| PE Ratio | 11.76 |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 1.282 |
| Price to Book Value | 1.373 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | 1.067 |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 0.2201 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 39.94% |
Profile
| Horiba Ltd provides analytical and measurement equipment. The automotive test systems segment contributes the largest percentage of revenue and supplies engine, driveline, brake, wind tunnel balance, and emissions test systems. The scientific segment sells instruments like pH meters, X-ray microscopes, and spectrometers. The semiconductor segment supplies mass flow controllers that are used in the semiconductor manufacturing process. The medical-diagnostic segment sells blood testing instruments and reagents for the in vitro diagnostics market. The process and environmental segment provides solutions associated with environmental regulations, such as air-pollution and water-quality analyzers. Horiba generates the largest proportion of its sales in Japan. |
| URL | http://www.horiba.co.jp |
| Investor Relations URL | N/A |
| HQ State/Province | N/A |
| Sector | Information Technology |
| Industry | Electronic Equipment, Instruments & Components |
| Equity Style | Mid Cap/Blend |
| Next Earnings Release | N/A |
| Last Earnings Release | N/A |
| Next Ex-Dividend Date | Dec. 27, 2024 |
| Last Ex-Dividend Date | Jun. 27, 2024 |
Ratings
Profile
| Horiba Ltd provides analytical and measurement equipment. The automotive test systems segment contributes the largest percentage of revenue and supplies engine, driveline, brake, wind tunnel balance, and emissions test systems. The scientific segment sells instruments like pH meters, X-ray microscopes, and spectrometers. The semiconductor segment supplies mass flow controllers that are used in the semiconductor manufacturing process. The medical-diagnostic segment sells blood testing instruments and reagents for the in vitro diagnostics market. The process and environmental segment provides solutions associated with environmental regulations, such as air-pollution and water-quality analyzers. Horiba generates the largest proportion of its sales in Japan. |
| URL | http://www.horiba.co.jp |
| Investor Relations URL | N/A |
| HQ State/Province | N/A |
| Sector | Information Technology |
| Industry | Electronic Equipment, Instruments & Components |
| Equity Style | Mid Cap/Blend |
| Next Earnings Release | N/A |
| Last Earnings Release | N/A |
| Next Ex-Dividend Date | Dec. 27, 2024 |
| Last Ex-Dividend Date | Jun. 27, 2024 |